Explore
Validate
LearnHPA001897
antibody from Atlas Antibodies
Targeting: ILF3
DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001897 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001897, RRID:AB_1078703
- Product name
- Anti-ILF3
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ILF3, Gene description: interleukin enhancer binding factor 3, 90kDa, Alternative Gene Names: DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1, Validated applications: ICC, IHC, WB, Uniprot ID: Q12906, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication
ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.
Sequestration by IFIT1 Impairs Translation of 2′O-unmethylated Capped RNA
Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy
Semler B, Moghimi S, Viktorova E, Gabaglio S, Zimina A, Budnik B, Wynn B, Sztul E, Belov G
PLOS Pathogens 2022;18(10):e1010906
PLOS Pathogens 2022;18(10):e1010906
ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
Liu Y, Li Y, Zhao Y, Liu Y, Fan L, Jia N, Zhao Q
Molecular Medicine Reports 2019
Molecular Medicine Reports 2019
ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.
Bremer HD, Landegren N, Sjöberg R, Hallgren Å, Renneker S, Lattwein E, Leonard D, Eloranta ML, Rönnblom L, Nordmark G, Nilsson P, Andersson G, Lilliehöök I, Lindblad-Toh K, Kämpe O, Hansson-Hamlin H
Scientific reports 2018 Mar 19;8(1):4852
Scientific reports 2018 Mar 19;8(1):4852
Sequestration by IFIT1 Impairs Translation of 2′O-unmethylated Capped RNA
Diamond M, Habjan M, Hubel P, Lacerda L, Benda C, Holze C, Eberl C, Mann A, Kindler E, Gil-Cruz C, Ziebuhr J, Thiel V, Pichlmair A
PLoS Pathogens 2013;9(10):e1003663
PLoS Pathogens 2013;9(10):e1003663
Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy
Stadler C, Hjelmare M, Neumann B, Jonasson K, Pepperkok R, Uhlén M, Lundberg E
Journal of Proteomics 2012;75(7):2236-2251
Journal of Proteomics 2012;75(7):2236-2251
No comments: Submit comment
No validations: Submit validation data